Total | Men | Women | ||||||||
N | n | % (95% CI) | N | n | % (95% CI) | N | n | % (95% CI) | OR* (95% CI) | |
HSV-2 | 200 | 163 | 81.5 (75.4 to 86.6) | 107 | 84 | 78.5 (69.5 to 85.9) | 93 | 79 | 85.0 (76.0 to 91.5) | 0.65 (0.31 to 1.35) |
Syphilis | 199 | 23 | 11.6 (7.5 to 16.8) | 106 | 13 | 12.3 (6.7 to 20.1) | 93 | 10 | 10.8 (5.3 to 18.9) | 1.16 (0.48 to 2.79) |
Active syphilis | 199 | 12 | 6.0 (3.2 to 10.3) | 106 | 6 | 5.7 (2.1 to 11.9) | 93 | 6 | 6.5 (2.4 to 13.5) | 0.87 (0.27 to 2.80) |
Bacterial vaginosis | 81 | 23 | 28.4 (18.9 to 39.5) | – | – | – | 81 | 23 | 28.4 (18.9 to 39.5) | – |
Chlamydia trachomatis | 198 | 4 | 2.0 (0.6 to 5.1) | 107 | 1 | 0.9 (0.0 to 5.1) | 91 | 3 | 3.3 (0.7 to 9.3) | 0.28 (0.03 to 2.71) |
Neisseria gonorrhoeae | 198 | 0 | 0 (0.0 to 1.8)† | 107 | 0 | 0 (0.0 to 3.4)† | 91 | 0 | 0 (0.0 to 4.0)† | – |
Mycoplasma gentitalium | 198 | 9 | 4.6 (2.1 to 8.5) | 107 | 1 | 0.9 (0.0 to 5.1) | 91 | 8 | 8.8 (3.9 to 16.6) | 0.10‡ (0.01 to 0.80) |
Trichomonas vaginalis | 198 | 12 | 6.1 (3.2 to 10.6) | 107 | 0 | 0 (0.0 to 3.4)† | 91 | 12 | 13.19 (7.0 to 21.9) | – |
Any acute STI¶ | 197 | 31 | 15.7 (10.9 to 21.6) | 106 | 8 | 7.5 (3.3 to 14.3) | 91 | 23 | 25.3 (16.7 to 35.5) | 0.24§ (0.10 to 0.57) |